Compugen Reports First Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Compugen (CGEN) PT Raised to $5 at Truist Securities
May 20, 2024 1:21 PM EDTTruist Securities analyst Asthika Goonewardene raised the price target on Compugen (NASDAQ: CGEN) to $5.00 (from $4.00) while maintaining a Buy rating.
The analyst comments "We are dismayed to learn that CGEN's efforts to develop COM701+COM902 in a particularly tough indication for immunotherapy... More
